Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT07715929
What this trial is testing

Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients

Who this might be right for
Atrial FibrillationObesity & OverweightCatheter Ablation
Yunlong Wang 710
Early research (Phase 1)Study completedNCT00302302
What this trial is testing

The Effects of L-arabinose on Intestinal Sucrase Activity in Man

Who this might be right for
Blood Glucose
University of Copenhagen 15
Early research (Phase 1)Active Not RecruitingNCT05202353
What this trial is testing

A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver

Who this might be right for
Obesity
Boehringer Ingelheim 29
Not applicableUnknownNCT05990374
What this trial is testing

Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years

Who this might be right for
Diabetes
Nanjing First Hospital, Nanjing Medical University 100
Testing effectiveness (Phase 2)Study completedNCT01425580
What this trial is testing

Liraglutide and Heart Failure in Type 2 Diabetes

Who this might be right for
Congestive Heart FailureType 2 Diabetes Mellitus
Thomas Nystrom 62
Early research (Phase 1)Study completedNCT02128022
What this trial is testing

Cardioprotective Effects of GLP-1 and Their Mechanisms

Who this might be right for
Angina Pectoris
Papworth Hospital NHS Foundation Trust 32
Post-approval studies (Phase 4)Looking for participantsNCT07419854
What this trial is testing

Restoring Facial Volume After GLP-1 Weight Loss With Radiesse

Who this might be right for
Volume Loss (Soft Tissue Ptosis or Atrophy )
Kalpna Kay Durairaj, MD, FACS 48
Not applicableStudy completedNCT01875575
What this trial is testing

Oral Glucose Stimulation in Normal-weight and Obese Volunteers

Who this might be right for
Endocrine System Diseases
University Hospital, Basel, Switzerland 24
Post-approval studies (Phase 4)Study completedNCT04387201
What this trial is testing

GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response

Who this might be right for
Glucose IntoleranceOverweight and ObesityDrug Effect+1 more
The University of Texas Health Science Center, Houston 23
Not applicableStudy completedNCT01058681
What this trial is testing

Impacts of Metabolic Variation on Neuroendocrine Control of Reproduction

Who this might be right for
Neuroendocrine Reproductive Status
Centre Hospitalier Universitaire Vaudois 9
Post-approval studies (Phase 4)UnknownNCT04122716
What this trial is testing

Combined Effects of GLP-1 Analogue and Exercise on Maintenance of Weight Loss and Health After Very-low Calorie Diet

Who this might be right for
Obesity
Signe Torekov 215
Not applicableStudy completedNCT01087372
What this trial is testing

Stress Hyperglycemia. Potential Role of Incretin Analogs

Who this might be right for
HyperglycemiaCritical Illness
Hospital Universitari Son Dureta 60
Post-approval studies (Phase 4)Study completedNCT06981936
What this trial is testing

This Randomized Trial Aims to Investigate the Efficacy of Balanced Nutritional Tablets-Comprehensive Multivitamin and Mineral Supplements- in Preventing Micronutrient Deficiencies Among Patients Utilizing GLP-1 RAs for Weight Loss in Comparison to a Placebo Control

Who this might be right for
Micronutrient Deficiencies
General Committee of Teaching Hospitals and Institutes, Egypt 150
Not applicableStudy completedNCT01363609
What this trial is testing

Effects of Glucagon Like Peptide-1(GLP-1) and Liraglutide on Brain Satiety and Reward Circuits and Feeding Behavior in Diabetes

Who this might be right for
ObesityType 2 Diabetes
Amsterdam UMC, location VUmc 50
Not applicableNot Yet RecruitingNCT07829016
What this trial is testing

GLP-1 Impacts on Weight Management

Who this might be right for
Weight ManagementDisordered Eating Behaviors
University of California, San Francisco 100
Early research (Phase 1)Ended earlyNCT05668936
What this trial is testing

A Thorough QTC Study to Assess the Effect of Cotadutide on Cardiac Repolarization in Healthy Participants

Who this might be right for
Non-alcoholic Steatohepatitis
AstraZeneca 31
Large-scale testing (Phase 3)WithdrawnNCT03508739
What this trial is testing

Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition

Who this might be right for
Diabetes Mellitus, Type 2Pre-diabeticHypertension+1 more
University of Pennsylvania
Large-scale testing (Phase 3)Study completedNCT03480022
What this trial is testing

Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS

Who this might be right for
Pre DiabetesPolycystic Ovary SyndromeObesity Android
Woman's 88
Not applicableStudy completedNCT02385630
What this trial is testing

Longitudinal Assessment of Gut Hormone Secretion Following Upper Gastrointestinal Surgery for Cancer

Who this might be right for
Esophageal NeoplasmsStomach NeoplasmsWeight Loss+1 more
St. James's Hospital, Ireland 40
Not applicableLooking for participantsNCT07789223
What this trial is testing

Weight and Metabolic Management Study

Who this might be right for
OverweightObesityWeight Maintenance
Elenzia 200
Next Page